Recent Updates — GRUSF
SEA Craft LLC, an affiliate of Grown Rogue International Inc., completed its initial product deliveries to select dispensaries in Illinois on October 22, 2026. This milestone follows the restart of cultivation at the Dwight facility in June 2026 after receiving state approval. The company currently operates with a flowering canopy of approximately 5,000 square feet and is working to expand capacity to roughly 10,000 square feet. Grown Rogue International Inc. is a flower-forward cannabis company producing craft-quality flower and related products.
Grown Rogue International Inc. completed the exercise of its second option to acquire an additional 26% ownership interest in its New Jersey subsidiary, ABCO Garden State LLC, increasing its total ownership to 70%. The transaction followed regulatory approval from the New Jersey Cannabis Regulatory Commission received on September 16, 2026. Grown Rogue has assumed majority control of ABCO's board of directors as part of the acquisition. The company also provided an update on its planned Phase II canopy expansion in New Jersey, targeting substantial construction completion by the end of 2026 to reach approximately 16,000 square feet of flowering capacity. Grown Rogue International Inc. is a flower-forward cannabis company producing craft-quality flower and products for markets in Oregon, Michigan, and New Jersey.
Grown Rogue International Inc. announced that cultivation activities have commenced at its affiliated licensed facility in Fridley, Minnesota, following operational approval from the state's Office of Cannabis Management on August 25, 2026. The Phase I buildout includes approximately 8,000 square feet of flowering canopy across five rooms within a larger 109,000-square-foot site capable of supporting up to 30,000 square feet. The company anticipates its first harvest in late Q4 2026, with products expected to reach consumers in Q1 2027. Grown Rogue International Inc. is a flower-forward cannabis company specializing in craft-quality cultivation and distribution.
Grown Rogue International Inc. entered into definitive agreements to facilitate its planned acquisition of PharmaCann Inc.'s New York license and assets through a newly formed joint venture, Grown Rogue New York LLC (GRNY). The Company holds a 51% interest in GRNY, while a capital partner invested $10 million for a 49% preferred equity stake. This investment includes an option to convert into approximately 18.2 million subordinate voting shares, representing roughly 7% dilution at current prices. Additionally, the capital partner committed up to $5 million via a drawable term loan and received 300,000 shares as a commitment fee. GRNY has assumed operational control of PCNY's four dispensaries and Hamptonburgh cultivation facility through interim agreements, including a secured loan of up to $9 million to support working capital and production ramp-up during the transition period pending regulatory approval.
Grown Rogue International Inc. reported unaudited financial results for the second quarter ended June 30, 2026, announcing Q2 revenue of $11.3 million, a 41% increase from the prior year period. The company posted an Adjusted EBITDA of $2.1 million and held $11.5 million in cash. Management raised its full-year 2026 revenue guidance to $38–$41 million and Adjusted EBITDA guidance to $7–9 million, while increasing 2027 revenue expectations to $55–$63 million. Operational updates highlighted continued expansion in New Jersey, Illinois, and Minnesota markets alongside yield improvements in Oregon and Michigan. Grown Rogue International Inc. is a flower-forward cannabis company specializing in the cultivation and distribution of designer-quality indoor cannabis products across multiple U.S. states.